126 91

Cited 0 times in

Change of angiogenesis-related protein expression by polydeoxyribonucleotide(PDRN) treatment in chondrocyte-like cells

Other Titles
 Polydeoxyribonucleotide (PDRN) 처리한 연골세포양 세포에서 혈관신생 관련 단백질 발현의 변화 
Authors
 김윤 
Issue Date
2018
Description
의학과
Abstract
The purpose of this study was to investigate the effect of polydeoxynucleotide (PDRN) on factors associated with angiogenesis after administration of PDRN in chondrocyte-like cells. Interleukin (IL)-1β or phosphate buffered saline (PBS) was used to treat human chondrocytic cell line in hypoxic condition for 24 h (IL-1β group or control group). PDRN was then used to treat IL-1β group cells for 24 h (PDRN group). Angiopoietin-2 (ANG-2), platelet-derived growth factor (PDGF) related to pro-angiogenesis and angiostatin and endostatin related to anti-angiogenesis were chosen by Label-based Human Antibody Array 1000 for further validation studies. Quantitative real-time reverse transcription polymerase chain reaction and western blot analysis validated that levels of PDGF and ANG-2 were significantly increased in the PDRN group compared to those in the control group or the IL-1β group. However, levels of endostatin and angiostatin were significantly decreased in the PDRN group compared to those in the control group or the IL-1β group. In in vitro scratch assay, wound closure was significantly increased in the PDRN group compared to that in the control group or the IL-1β group. Moreover, PDRN decreased expression of MMP13 (a catabolic factor for OA) but increased expression of aggrecan (an anabolic factor for OA). These data suggest that PDRN may promote angiogenesis and wound healing via down-regulation of catabolism and up-regulation of anabolism in chondrocyte-like cells.
Files in This Item:
T014927.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Others (기타) > 2. Thesis
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/166415
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse